Cegedim Dendrite Survey Uncovers 35% of Pharmaceutical Executives Concerned Over Changing Commercial Business Models

BEDMINSTER, N.J.--(BUSINESS WIRE)--Cegedim Dendrite, the world’s leading provider of pharmaceutical-specific Customer Relationship Management (CRM) solutions with a 35 percent global market share, today announced the results of the Cegedim Dendrite 2010 Pharma Insights Survey, a market research study conducted in May this year in the Americas.

Back to news